A Mig-14-like protein (PA5003) affects antimicrobial peptide recognition in Pseudomonas aeruginosa

Microbiology

Volumn 157, Issue 9, 2011, Pages 2647-2657

  Jochumsen, Nicholas ^a   Liu, Yang ^a   Molin, Søren ^a   Folkesson, Anders ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BACTERIUM LIPOPOLYSACCHARIDE; CARBENICILLIN; CATIONIC ANTIMICROBIAL PEPTIDE; CHLORAMPHENICOL; COLISTIN; DNA; GENTAMICIN; KANAMYCIN; NOVISPIRIN G10; POLYPEPTIDE ANTIBIOTIC AGENT; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; BIOFILM; CONFOCAL LASER MICROSCOPY; DELETION MUTANT; ESCHERICHIA COLI; FLUORESCENCE ACTIVATED CELL SORTER; GENE EXPRESSION; HYDRODYNAMICS; MUTAGENESIS; NONHUMAN; OPERON; PA5003 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PSEUDOMONAS AERUGINOSA; TRANSPOSON;

ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL PROTEINS; BIOFILMS; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; LIPOPOLYSACCHARIDES; MUTAGENESIS, INSERTIONAL; OPERON; PSEUDOMONAS AERUGINOSA;

PSEUDOMONAS AERUGINOSA;

EID: 80052363998     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.049445-0     Document Type: Article

References (58)

1. Ausubel, F.M., Brent, M. R., Kingston, R. E., Moore, D.D., Siedman, J. G., Smith, J. A. & Struhl, K. (1996). Current Protocols in Molecular Biology. New York: Wiley.
2. Bader, M. W., Sanowar, S., Daley, M. E., Schneider, A. R., Cho, U., Xu, W., Klevit, R. E., Le Moual, H. & Miller, S. I. (2005). Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell 122, 461-472.
3. Bailey, J. & Manoil, C. (2002). Genome-wide internal tagging of bacterial exported proteins. Nat Biotechnol 20, 839-842.
4. Bollenbach, T., Quan, S., Chait, R. & Kishony, R. (2009). Nonoptimal microbial response to antibiotics underlies suppressive drug interactions. Cell 139, 707-718.
5. Breazeale, S. D., Ribeiro, A. A. & Raetz, C. R. (2002). Oxidative decarboxylation of UDP-glucuronic acid in extracts of polymyxinresistant Escherichia coli. Origin of lipid A species modified with 4-amino-4-deoxy-L-arabinose. J Biol Chem 277, 2886-2896.
6. Breazeale, S. D., Ribeiro, A. A. & Raetz, C. R. (2003). Origin of lipid A species modified with 4-amino-4-deoxy-L-arabinose in polymyxinresistant mutants of Escherichia coli. An aminotransferase (ArnB) that generates UDP-4-deoxy-L-arabinose. J Biol Chem 278, 24731-24739.
7. Breukink, E., Wiedemann, I., van Kraaij, C., Kuipers, O. P., Sahl, H. & de Kruijff, B. (1999). Use of the cell wall precursor lipid II by a poreforming peptide antibiotic. Science 286, 2361-2364.
8. Brodsky, I. E., Ernst, R. K., Miller, S. I. & Falkow, S. (2002). mig-14 is a Salmonella gene that plays a role in bacterial resistance to antimicrobial peptides. J Bacteriol 184, 3203-3213.
9. Brodsky, I. E., Ghori, N., Falkow, S. & Monack, D. (2005). Mig-14 is an inner membrane-associated protein that promotes Salmonella typhimurium resistance to CRAMP, survival within activated macrophages and persistent infection. Mol Microbiol 55, 954-972.
10. Brogden, K. A. (2005). Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3, 238-250.
11. Brötz, H., Bierbaum, G., Leopold, K., Reynolds, P. E. & Sahl, H. G. (1998). The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II. Antimicrob Agents Chemother 42, 154-160.
12. Ceri, H., Olson, M. E., Stremick, C., Read, R. R., Morck, D. & Buret, A. (1999). The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37, 1771-1776.
13. Choi, K. H. & Schweizer, H. P. (2005). An improved method for rapid generation of unmarked Pseudomonas aeruginosa deletion mutants. BMC Microbiol 5, 30.
14. Christensen, B. B., Sternberg, C., Andersen, J. B., Palmer, R. J., Jr, Nielsen, A. T., Givskov, M. & Molin, S. (1999). Molecular tools for study of biofilm physiology. Methods Enzymol 310, 20-42.
15. Clark, D. J. & Maaloe, O. (1967). DNA replication and division cycle in Escherichia coli. J Mol Biol 23, 99-112.
16. Conly, J. & Johnston, B. (2006). Colistin: the phoenix arises. Can J Infect Dis Med Microbiol 17, 267-269.
17. Conrad, R. S. & Galanos, C. (1989). Fatty acid alterations and polymyxin B binding by lipopolysaccharides from Pseudomonas aeruginosa adapted to polymyxin B resistance. Antimicrob Agents Chemother 33, 1724-1728.
18. Ernst, R. K., Yi, E. C., Guo, L., Lim, K. B., Burns, J. L., Hackett, M. & Miller, S. I. (1999). Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 286, 1561-1565.
19. Fernández, L., Gooderham, W. J., Bains, M., McPhee, J. B., Wiegand, I. & Hancock, R. E. (2010). Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS. Antimicrob Agents Chemother 54, 3372-3382.
20. Folkesson, A., Haagensen, J. A., Zampaloni, C., Sternberg, C. & Molin, S. (2008). Biofilm induced tolerance towards antimicrobial peptides. PLoS ONE 3, e1891.
21. Frederiksen, B., Koch, C. & Høiby, N. (1997). Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 23, 330-335.
22. 2+-deficient medium. J Bacteriol 117, 302-311.
23. Gunn, J. S. (2001). Bacterial modification of LPS and resistance to antimicrobial peptides. J Endotoxin Res 7, 57-62.
24. Gunn, J. S., Lim, K. B., Krueger, J., Kim, K., Guo, L., Hackett, M. & Miller, S. I. (1998). PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol Microbiol 27, 1171-1182.
25. Haagensen, J. A., Klausen, M., Ernst, R. K., Miller, S. I., Folkesson, A., Tolker-Nielsen, T. & Molin, S. (2007). Differentiation and distribution of colistin-and sodium dodecyl sulfate-tolerant cells in Pseudomonas aeruginosa biofilms. J Bacteriol 189, 28-37.
26. Hiemstra, P. S., Fernie-King, B. A., McMichael, J., Lachmann, P. J. & Sallenave, J. M. (2004). Antimicrobial peptides: mediators of innate immunity as templates for the development of novel anti-infective and immune therapeutics. Curr Pharm Des 10, 2891-2905.
27. Hoeprich, P. D. (1970). The polymyxins. Med Clin North Am 54, 1257-1265.
28. Høiby, N., Krogh Johansen, H., Moser, C., Song, Z., Ciofu, O. & Kharazmi, A. (2001). Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect 3, 23-35.
29. Jacobs, M. A., Alwood, A., Thaipisuttikul, I., Spencer, D., Haugen, E., Ernst, S., Will, O., Kaul, R., Raymond, C. & other authors (2003). Comprehensive transposon mutant library of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 100, 14339-14344.
30. Khandelia, H. & Kaznessis, Y. N. (2005). Molecular dynamics simulations of helical antimicrobial peptides in SDS micelles: what do point mutations achieve? Peptides 26, 2037-2049.
31. King, J. D., Kocíncová, D., Westman, E. L. & Lam, J. S. (2009). Review: lipopolysaccharide biosynthesis in Pseudomonas aeruginosa. Innate Immun 15, 261-312.
32. Koch, B., Jensen, L. E. & Nybroe, O. (2001). A panel of Tn7-based vectors for insertion of the GFP marker gene or for delivery of cloned DNA into Gram-negative bacteria at a neutral chromosomal site. J Microbiol Methods 45, 187-195.
33. Lam, J., Matewish, M. & Poon, K. K. H. (2004). Lipopolysaccharides of Pseudomonas aeruginosa. In Pseudomonas, vol. 3, Biosynthesis of Macromolecules and Molecular Metabolism, pp. 341-361. Edited by J. L. Ramos.
34. Lambertsen, L., Sternberg, C. & Molin, S. (2004). Mini-Tn7 transposons for site-specific tagging of bacteria with fluorescent proteins. Environ Microbiol 6, 726-732.
35. Landman, D., Georgescu, C., Martin, D. A. & Quale, J. (2008). Polymyxins revisited. Clin Microbiol Rev 21, 449-465.
36. Littlewood, J. M., Miller, M. G., Ghoneim, A. T. & Ramsden, C. H. (1985). Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis. Lancet 325, 865.
37. Manoil, C. (2000). Tagging exported proteins using Escherichia coli alkaline phosphatase gene fusions. Methods Enzymol 326, 35-47.
38. Matewish, M. (2004). The functional role of lipopolysaccharide in the cell envelope and surface proteins of Pseudomonas aeruginosa. PhD thesis, University of Guelph, Canada.
39. McPhee, J. B., Lewenza, S. & Hancock, R. E. (2003). Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol Microbiol 50, 205-217.
40. Moskowitz, S. M., Ernst, R. K. & Miller, S. I. (2004). PmrAB, a twocomponent regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A. J Bacteriol 186, 575-579.
41. Nickel, J. C., Ruseska, I., Wright, J. B. & Costerton, J. W. (1985). Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob Agents Chemother 27, 619-624.
42. Pamp, S. J., Gjermansen, M., Johansen, H. K. & Tolker-Nielsen, T. (2008). Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol Microbiol 68, 223-240.
43. Perron, G. G., Zasloff, M. & Bell, G. (2006). Experimental evolution of resistance to an antimicrobial peptide. Proc Biol Sci 273, 251-256.
44. Prince, A. S. (2002). Biofilms, antimicrobial resistance, and airway infection. N Engl J Med 347, 1110-1111.
45. Sawai, M. V., Waring, A. J., Kearney, W. R., McCray, P. B., Jr, Forsyth, W. R., Lehrer, R. I. & Tack, B. F. (2002). Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides. Protein Eng 15, 225-232.
46. Schneider, T., Kruse, T., Wimmer, R., Wiedemann, I., Sass, V., Pag, U., Jansen, A., Nielsen, A. K., Mygind, P. H. & other authors (2010). Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II. Science 328, 1168-1172.
47. Southward, C. M. & Surette, M. G. (2002). The dynamic microbe: green fluorescent protein brings bacteria to light. Mol Microbiol 45, 1191-1196.
48. Srinivas, N., Jetter, P., Ueberbacher, B. J., Werneburg, M., Zerbe, K., Steinmann, J., Van der Meijden, B., Bernardini, F., Lederer, A. & other authors (2010). Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa. Science 327, 1010-1013.
49. Steinstraesser, L., Tack, B. F., Waring, A. J., Hong, T., Boo, L. M., Fan, M. H., Remick, D. I., Su, G. L., Lehrer, R. I. & Wang, S. C. (2002). Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns. Antimicrob Agents Chemother 46, 1837-1844.
50. Storm, D. R., Rosenthal, K. S. & Swanson, P. E. (1977). Polymyxin and related peptide antibiotics. Annu Rev Biochem 46, 723-763.
51. Travis, S. M., Anderson, N. N., Forsyth, W. R., Espiritu, C., Conway, B. D., Greenberg, E. P., McCray, P. B., Jr, Lehrer, R. I., Welsh, M. J. & Tack, B. F. (2000). Bactericidal activity of mammalian cathelicidinderived peptides. Infect Immun 68, 2748-2755.
52. Trent, M. S., Ribeiro, A. A., Doerrler, W. T., Lin, S., Cotter, R. J. & Raetz, C. R. (2001). Accumulation of a polyisoprene-linked amino sugar in polymyxin-resistant Salmonella typhimurium and Escherichia coli: structural characterization and transfer to lipid A in the periplasm. J Biol Chem 276, 43132-43144.
53. Vaara, M., Vaara, T., Jensen, M., Helander, I., Nurminen, M., Rietschel, E. T. & Mäkelä, P. H. (1981). Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium. FEBS Lett 129, 145-149.
54. Valdivia, R. H., Cirillo, D. M., Lee, A. K., Bouley, D. M. & Falkow, S. (2000). mig-14 is a horizontally acquired, host-induced gene required for Salmonella enterica lethal infection in the murine model of typhoid fever. Infect Immun 68, 7126-7131.
55. Winfield, M. D. & Groisman, E. A. (2004). Phenotypic differences between Salmonella and Escherichia coli resulting from the disparate regulation of homologous genes. Proc Natl Acad Sci U S A 101, 17162-17167.
56. Winsor, G. L., Van Rossum, T., Lo, R., Khaira, B., Whiteside, M. D., Hancock, R. E. & Brinkman, F. S. (2009). Pseudomonas Genome Database: facilitating user-friendly, comprehensive comparisons of microbial genomes. Nucleic Acids Res 37 (Database issue), D483-D488.
57. Zaslaver, A., Bren, A., Ronen, M., Itzkovitz, S., Kikoin, I., Shavit, S., Liebermeister, W., Surette, M. G. & Alon, U. (2006). A comprehensive library of fluorescent transcriptional reporters for Escherichia coli. Nat Methods 3, 623-628.
58. Zasloff, M. (2002). Antimicrobial peptides of multicellular organisms. Nature 415, 389-395.